NCT01767857 2021-06-29
XCITE
Janssen Research & Development, LLC
Phase 3 Terminated
Clinical Trials
3 trialsNCT02138422 2021-03-01
A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer
Janssen Research & Development, LLC
Phase 3 Completed
NCT01260545 2021-02-16
Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
Janssen Research & Development, LLC
Phase 1 Completed